Two lanes most sellers do not separate
Microdosing appears on plenty of sites as a talking point. Here it is a product with its own price and its own description: a lower, fixed dose that does not titrate up, sold beside the full-dose version of the same drug at a different figure. A few other rows here run a microdose lane — Remedy Meds and the Center for Medical Weight Loss among them — but most treat it as a talking point.
The oral tablet is the other one. The page calls it a needle-free alternative to the weekly injection and prices it at the same figure as the full-dose injectable tirzepatide, which is a real choice a reader can make on the page rather than after an intake.
Both lanes exist for semaglutide and tirzepatide, so a reader can compare four combinations without talking to anyone.
It tells you what the price includes, and on one page what it covers
The FAQ on the product page answers the cost question directly and says the figure includes the provider consult, the medication if approved, and shipping, with no separate consult or membership fee. That is a complete answer, and few sellers here give one.
The tablet page goes further than most on this roster and states the length of the supply in weeks. That single parenthesis is the difference between a figure a reader can annualise and a figure they have to guess at.
The two injectable pages do not repeat it. They say a monthly supply and stop. We store the tablet as a non-monthly rate because its own page says so, and the injectables as monthly because theirs do — the site is the source of the difference, not us.
The zero that is not a price
Every product page renders the price twice with a zero between the two, a default emitted by the shopping platform when no compare-at value is set. It is not an offer and it is not a discount.
It is worth naming because it is the exact shape of defect that turns an automated price sweep into a false record, and because a reader skimming the block can easily read the wrong one of the three figures.
Who is behind it
The privacy policy describes the seller as a Texas limited liability company at a Fort Worth address and gives no fuller corporate name. The trading name is the only name.
No compounding pharmacy is named — the pages say a licensed compounding pharmacy and leave it there. No prescribing clinician is named, and no list of served states appears.
The GLP-1 lanes sit inside a wider catalogue that also sells peptides, a nasal spray, skin products and hormone lines, so this is a storefront with a weight-loss aisle rather than a weight-loss service.
It carries an FDA warning letter issued in June 2026 over false and misleading claims and misbranding. That is a disclosure and it does not move this seller's position here.
Fitish's published pricing
| Medication | Price | Verified |
|---|---|---|
| Semaglutide (compounded) | $219/moper monthly supply — the product page states "Pricing is for a monthly supply" and its FAQ answers the cost question with "$219 for a monthly supply, including your provider consult, the medication if approved, and shipping. No separate consult or membership fees." | September 2026source |
| Semaglutide (compounded) | $179/moper monthly supply, for the microdose lane — the same page prints "Microdose semaglutide, $179 / monthly supply" and describes it as "a lower, fixed dose ... It does not titrate up" | September 2026source |
| Tirzepatide (compounded) | $339/moper monthly supply — the product page states "Pricing is for a monthly supply" | September 2026source |
| Tirzepatide (compounded) | $269/moper monthly supply, for the microdose lane — "Microdose tirzepatide, $269 / monthly supply" | September 2026source |
| Tirzepatide (compounded-oral) | $339the tablet page states the unit itself — "Pricing is for a monthly supply (4 weeks)" — and four-week supplies bought on a monthly cadence come to thirteen a year, not twelve; ⛔ the two injectable pages on the same site say "a monthly supply" with no week count, which is why only this row is stored as non-monthly | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 264 providers reviewed here are paid partners today; the other 260 are not. See how this works.
See Fitish's current price →Good fit if
- Buyers who want a microdose lane priced as its own product rather than described as an option.
- Readers who would rather swallow a tablet than inject.
- People who want a price on a public page with no quiz in front of it.
- Anyone who wants the consult and shipping folded into one figure and said so in writing.
Look elsewhere if
- Readers who need a brand-name GLP-1.
- Buyers who need the compounding pharmacy named.
- Anyone who needs to know their state is served before starting.
- People who want a full corporate name and officers behind the trading name.
How this review was verified
- Read the homepage, three product pages and the privacy policy on 7 September 2026, comparing requested to effective URLs, with a nonsense path on the same host in the same run — it returned a 404 carrying a body larger than most real pages here, so the status code decided.
- Took every figure from a product page, never from the collection grid, because the grid emits a zero for each item that a scan would harvest as a price.
- Recorded the tablet's unit from the parenthesis printed on its own page, and deliberately did not copy that week count across to the injectable pages, which do not state one.
- Read the cost FAQ in full before recording the membership position, rather than inferring it from the absence of a fee line.
- Screened the live FDA warning-letter datatable with a positive control returning exactly one row and a nonsense control returning none in the same run, then fetched the letter and confirmed its body names this seller's domain.